iRadimed, which makes non-magnetic MRI-safe IV infusion pumps, announced terms for its IPO on Wednesday. The Winter Park, FL-based company plans to raise nearly $10 million by offering 1.75 million shares at a price range of $5 to $6. At the midpoint of the proposed range, iRadimed would command a fully diluted market value of $64 million.
iRadimed, which was founded in 1992 and booked $12 million in sales for the 12 months ended March 31, 2014, plans to list on the NASDAQ under the symbol IRMD. iRadimed initially filed confidentially on April 25, 2014. Roth Capital is the sole bookrunner on the deal. A pricing date has not been set.
